83 related articles for article (PubMed ID: 22877634)
1. 2-Amino-1,3,4-thiadiazole derivative (FABT) inhibits the extracellular signal-regulated kinase pathway and induces cell cycle arrest in human non-small lung carcinoma cells.
Juszczak M; Matysiak J; Szeliga M; Pożarowski P; Niewiadomy A; Albrecht J; Rzeski W
Bioorg Med Chem Lett; 2012 Sep; 22(17):5466-9. PubMed ID: 22877634
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates.
Yan H; Zhu Y; Liu B; Wu H; Li Y; Wu X; Zhou Q; Xu K
Br J Nutr; 2011 Dec; 106(12):1779-91. PubMed ID: 21733335
[TBL] [Abstract][Full Text] [Related]
3. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway.
Wang H; Wu C; Wan S; Zhang H; Zhou S; Liu G
Toxicology; 2013 Jun; 308():104-12. PubMed ID: 23562787
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
[TBL] [Abstract][Full Text] [Related]
5. The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.
Mukhopadhyay P; Ali MA; Nandi A; Carreon P; Choy H; Saha D
Cancer Res; 2006 Feb; 66(3):1758-66. PubMed ID: 16452236
[TBL] [Abstract][Full Text] [Related]
6. Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4-thiadiazole based compound.
Rzeski W; Matysiak J; Kandefer-Szerszeń M
Bioorg Med Chem; 2007 May; 15(9):3201-7. PubMed ID: 17350846
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells.
Ko JC; Tsai MS; Chiu YF; Weng SH; Kuo YH; Lin YW
J Pharmacol Exp Ther; 2011 Jul; 338(1):184-94. PubMed ID: 21444628
[TBL] [Abstract][Full Text] [Related]
9. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin.
Sun SH; Huang HC; Huang C; Lin JK
Eur J Pharmacol; 2012 Sep; 690(1-3):22-30. PubMed ID: 22705896
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of the pemetrexed-activated MAPK pathway via sorafenib is involved in the synergistic mechanism of sorafenib subsequent potentiation of pemetrexed cytotoxicity in EGFR TKI-resistant cell lines.
Jiang Y; Li C; Ma Y; Chen J; Li Y; Chen L
Clin Lab; 2012; 58(5-6):551-61. PubMed ID: 22783588
[TBL] [Abstract][Full Text] [Related]
11. ERK activation in arsenite-treated G1-enriched CL3 cells contributes to survival, DNA repair inhibition, and micronucleus formation.
Li JP; Lin JC; Yang JL
Toxicol Sci; 2006 Jan; 89(1):164-72. PubMed ID: 16207941
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic effects of a high performance liquid chromatography (HPLC) fraction of Antrodia camphorata mycelia are mediated by down-regulation of the expressions of four tumor-related genes in human non-small cell lung carcinoma A549 cell.
Chan YY; Chang CS; Chien LH; Wu TF
J Ethnopharmacol; 2010 Feb; 127(3):652-61. PubMed ID: 19995598
[TBL] [Abstract][Full Text] [Related]
13. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase.
Han S; Sidell N; Roman J
Cancer Lett; 2005 Feb; 219(1):71-81. PubMed ID: 15694666
[TBL] [Abstract][Full Text] [Related]
14. Role of Rad51 down-regulation and extracellular signal-regulated kinases 1 and 2 inactivation in emodin and mitomycin C-induced synergistic cytotoxicity in human non-small-cell lung cancer cells.
Su YJ; Tsai MS; Kuo YH; Chiu YF; Cheng CM; Lin ST; Lin YW
Mol Pharmacol; 2010 Apr; 77(4):633-43. PubMed ID: 20042515
[TBL] [Abstract][Full Text] [Related]
15. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells.
Chen YL; Lin PC; Chen SP; Lin CC; Tsai NM; Cheng YL; Chang WL; Lin SZ; Harn HJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):746-56. PubMed ID: 17715378
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
17. MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
Zhang X; Teng Y; Yang F; Wang M; Hong X; Ye LG; Gao YN; Chen GY
Oncol Rep; 2015 May; 33(5):2599-605. PubMed ID: 25738322
[TBL] [Abstract][Full Text] [Related]
18. Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase.
Zhao Y; Jiang W; Li B; Yao Q; Dong J; Cen Y; Pan X; Li J; Zheng J; Pang X; Zhou H
Int Immunopharmacol; 2011 Dec; 11(12):2039-46. PubMed ID: 21907831
[TBL] [Abstract][Full Text] [Related]
19. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
20. Antroquinonol inhibits NSCLC proliferation by altering PI3K/mTOR proteins and miRNA expression profiles.
Kumar VB; Yuan TC; Liou JW; Yang CJ; Sung PJ; Weng CF
Mutat Res; 2011 Feb; 707(1-2):42-52. PubMed ID: 21185843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
